Number of the records: 1  

inhibítory imunitných kontrolných bodov

  1. Record numberd000082082
    Date06.06.2025
    TypeM
    Topical terminhibítory imunitných kontrolných bodov
    Other termEnglish (Pseudonym) CTLA-4 Inhibitor
    English (Pseudonym) CTLA-4 Inhibitors
    English (Pseudonym) Cytotoxic T-Lymphocyte-Associated Protein 4 Inhibitor
    English (Pseudonym) Cytotoxic T-Lymphocyte-Associated Protein 4 Inhibitors
    English (Pseudonym) Immune Checkpoint Blockade
    English (Pseudonym) Immune Checkpoint Blockers
    English (Pseudonym) Immune Checkpoint Inhibition
    English (Pseudonym) Immune Checkpoint Inhibitor
    English (Pseudonym) PD-1 Inhibitor
    English (Pseudonym) PD-1 Inhibitors
    English (Pseudonym) PD-1-PD-L1 Blockade
    English (Pseudonym) PD-L1 Inhibitor
    English (Pseudonym) PD-L1 Inhibitors
    English (Pseudonym) Programmed Cell Death Protein 1 Inhibitor
    English (Pseudonym) Programmed Cell Death Protein 1 Inhibitors
    English (Pseudonym) Programmed Death-Ligand 1 Inhibitors
    Slovak (Pseudonym) inhibítory kontrolných bodov imunitnej reakcie
    Slovak (Pseudonym) CTLA-4 inhibítor
    Slovak (Pseudonym) inhibítory CTLA-4
    Slovak (Pseudonym) inhibítor s cytotoxickými T-lymfocytmi asociovaného proteínu-4
    Slovak (Pseudonym) inhibítory proteínu-4 asociovaného s cytotoxickými T-lymfocytmi
    Slovak (Pseudonym) PD-1-PD-L1 blokáda
    Slovak (Pseudonym) blokovanie PD-1/PD-L1
    Slovak (Pseudonym) blokovanie imunitných kontrolných bodov
    Slovak (Pseudonym) blokátory imunitných kontrolných bodov
    Slovak (Pseudonym) inhibícia imunitných kontrolných bodov
    Slovak (Pseudonym) inhibítor imunitných kontrolných bodov
    Slovak (Pseudonym) PD-1 inhibítor
    Slovak (Pseudonym) inhibítory PD-1
    Slovak (Pseudonym) PD-L1 inhibítor
    Slovak (Pseudonym) inhibítor proteínu programovanej bunkovej smrti-1
    Slovak (Pseudonym) inhibítory ligandu programovanej bunkovej smrti-1
    UDCD27.505.519.507D27.505.954.248.384.500
    NoteDrugs that block negative regulator IMMUNE CHECKPOINT proteins (e.g., PD-1 RECEPTOR and CTLA-4 ANTIGEN) thereby increasing suppressed immune activation in immunotherapies.
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.